Related Experiment Video
Updated: May 11, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Risk Management of Medication Errors: Improving the Quality of Pharmacotherapeutic Practice
Richard Anthony Despott1, Patricia Vella Bonanno1,2, Charmaine Gauci1
1Department for Health Regulation, St Luke's Hospital, Pietà, Malta.
Abstract:
A key challenge when identifying opportunities and prioritizing strategies for quality improvement of healthcare services is an accurate design specification against which clinical performance can be assessed. This study aimed to explore evidence-based methods as a more effective framework for quality improvement in pharmacotherapeutic practices. A stakeholder management matrix was adapted to differentiate the dimensions of the theoretical construct for quality of care and establish a design specification for healthcare practice. A review of drug-related problems (DRPs) associated with preventable medication errors was carried out on individual cases of adverse drug events (ADRs) reported in the EudraVigilance database system. The potential impact of strategies aimed at preventing the underlying root cause medication error (RCME) was evaluated according to the relative frequency and severity of patient harm identified with DRPs. Out of 1750 medication errors reported in the EudraVigilance database, 1300 cases of preventable DRPs were identified, of which 531 (41%) were classified as prescribing errors, 260 (20%) as dispensing errors, and 509 (39%) as errors encountered in drug administration. The highest risk scores were associated with case-based prescribing errors and rule-based drug administration errors. The research builds on a quality risk management approach to assess how targeted interventions may reduce the risk of medication errors. The theoretical model provided a basis for establishing the strategic domains of quality in health care and comparing quality improvement strategies in drug therapy. The measures required to mitigate the highest risk of error include medication review of prescribing practices, unit dose dispensing systems and in-line quality control to avoid treatment administration errors, and patient education in dispensing practice. This framework is independent of the healthcare or institutional setting and may be applied on a broad scale for sharing best practices, harmonization of standards, and elimination of disparities in treatment outcomes.
Related Concept Videos
Errors occurring during blood pressure monitoring
Several factors...
Drug Therapy
Antianxiety Medications
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Guidelines for Nursing Documentation I
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

